企業プロフィール
Processa Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- PCSA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
2.13 USD (-12.35%)
終値
最終更新: 2026年8月17日
8.03M USD
時価総額
株価変動の要因
As of Aug 17, 2026, PCSA closed down 12.3% at $2.13. No new same-company headline was identified in the current news window.
企業概要
事業概要
Processa Pharmaceuticals is a development-stage company focused on improving the safety and efficacy of existing oncology drugs through next-generation formulations and combinations. Its story centers on making known medicines more usable in difficult cancer settings.
所在地とセクター分類
Processa is headquartered in the United States and listed on NASDAQ. It sits in small-cap biopharmaceutical development.
ビジネスモデルの特徴
The business depends on clinical progress, formulation strategy, and the ability to advance a narrow pipeline with limited resources. Investors typically watch proof-of-concept data and partnership or financing activity.
バイオ業界での位置付け
Processa occupies a niche oncology-development position within biotech. It is a small-cap story where the commercial value depends on whether modified therapies can truly improve outcomes.
今後のカタリスト
- Processa’s catalysts are its rare-disease and oncology programs, especially any development update that clarifies which assets still matter. The company needs a cleaner clinical path.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。